• Investigational Gout Drugs Do Well in Clinical Trials
    Investigational Gout Drugs Do Well in Clinical Trials
    More recently, explains to you of BioCryst Pharmaceuticals rose 12% upon the release of the results of its phase 2b randomized, double-blind, study of the investigational gout drug BCX4208.
  • New Gout Drug Krystexxa Exceeds Target
    New Gout Drug Krystexxa Exceeds Target
    The pegloticase mechanism of action is different than that of other gout drugs - it converts uric acid to a nontoxic byproduct that is easily excreted in the urine.
  • Utilizing Pure organic Drugs to heal Gout Invade
    Utilizing Pure organic Drugs to heal Gout Invade
    In a different analyze, it was asserted that VAD is really a better producer of the xanthine oxidase when compared with typical gout drug allopurinol.